Effects of the antihypertensive drug captopril on human salivary secretion rate and composition. 1995

T Nederfors, and C Dahlof, and T Ericsson, and S Twetman
Department of Pharmacology and Clinical Pharmacology, Faculty of Odontology, Goeteborg University, Sweden.

The effects of the antihypertensive drug captopril on salivary secretion rate and composition was evaluated in 24 healthy adults (18-46 yr) according to a double-blind, cross-over design. Unstimulated and paraffin-chewing stimulated whole saliva and 3% citric acid stimulated parotid and submandibular-sublingual (SM-SL) secretion were collected at 10.30 a.m. (about 2h after intake of breakfast) on day 0 (baseline values), day 1 (experimental acute values) and day 7 (experimental chronic values) in each treatment period. In 8 of the subjects, also morning samples were collected at 7.30 a.m., with the test subjects in a fasting condition. Whole saliva was assessed for flow rate and for concentrations of sodium, potassium, chloride, calcium and phosphate. In addition, parotid and SM-SL secretion were assessed for concentrations of total protein, hexosamine, sialic acid, lactoferrin and salivary IgA and for activities of amylase, lysozyme and salivary peroxidase. During treatment with the angiotensin converting enzyme inhibitor captopril, the secretion rates tended to increase for unstimulated and paraffin-chewing stimulated whole saliva and for parotid secretion. For salivary composition, no alterations were observed in any of the collected secretions.

UI MeSH Term Description Entries
D007071 Immunoglobulin A, Secretory The principle immunoglobulin in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. The complete molecule (around 400 kD) is composed of two four-chain units of IMMUNOGLOBULIN A, one SECRETORY COMPONENT and one J chain (IMMUNOGLOBULIN J-CHAINS). Colostral IgA,IgA, Exocrine,IgA, Secretory,SIgA,Secretory IgA,Secretory Immunoglobulin A,Exocrine IgA,IgA, Colostral
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010306 Parotid Gland The largest of the three pairs of SALIVARY GLANDS. They lie on the sides of the FACE immediately below and in front of the EAR. Gland, Parotid,Glands, Parotid,Parotid Glands
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D002712 Chlorides Inorganic compounds derived from hydrochloric acid that contain the Cl- ion. Chloride,Chloride Ion Level,Ion Level, Chloride,Level, Chloride Ion
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

T Nederfors, and C Dahlof, and T Ericsson, and S Twetman
January 1970, Journal of dental research,
T Nederfors, and C Dahlof, and T Ericsson, and S Twetman
September 1981, Refu'at ha-peh veha-shinayim (Tel Aviv, Israel : 1969),
T Nederfors, and C Dahlof, and T Ericsson, and S Twetman
June 2004, Molecular and cellular biochemistry,
T Nederfors, and C Dahlof, and T Ericsson, and S Twetman
May 1973, Archives of oral biology,
T Nederfors, and C Dahlof, and T Ericsson, and S Twetman
January 2007, Clinical nephrology,
T Nederfors, and C Dahlof, and T Ericsson, and S Twetman
December 1989, Scandinavian journal of dental research,
T Nederfors, and C Dahlof, and T Ericsson, and S Twetman
August 2004, Archives of oral biology,
T Nederfors, and C Dahlof, and T Ericsson, and S Twetman
January 1982, Quarterly journal of experimental physiology (Cambridge, England),
T Nederfors, and C Dahlof, and T Ericsson, and S Twetman
February 1972, The Journal of physiology,
Copied contents to your clipboard!